Dextranomer/Hyalouronic Acid Copolymer Injection for Treatment of Children with Primary Vesicoureteral Reflux: Long-Term Follow-up

Purpose: We aim to present our 5 years results with Dextranomer/Hyalouronic Acid (Dx/HA) sub-ureteral injection for treatment of children with primary vesico ureteric reflux (VUR). PATIENTS AND METHODS: The retrospective cohort study which was performed at tertiary referral center in Cairo. Children underwent Dx/HA injection for treatment of the primary VUR were reviewed. Only those he had full medical record dating 5 years or earlier included into the study. Results: Sixty patients, 25 boys and 35 girls in total 82 ureters had refluxed underwent DX/HA injections. The patients' average age was 5.70 years. Eight (9.7%) of the 82 ureters that were treated failed all three injections, leaving 74 (90.3%) of them completely cured. Conclusion: This acceptable improvement sustainability of the DX/HA sub-uretral injection in children with 1ry VUR highlights the benefits of this procedures. The minimally invasive nature, the short hospital stay are definite advantages.